Back to Search
GARY R. BRIGHAM M.D.
M.D.
Clinical Cardiac Electrophysiology Physician
NPI: 1972500999IndividualAccepts Medicare
Specialties, Licenses & Credentials
Clinical Cardiac Electrophysiology PhysicianPrimary
Internal Medicine — Clinical Cardiac Electrophysiology
Code: 207RC0001X
01041362(IN)
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
01041362A(IN)
Education
UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Class of 1990
Research & Publications (12)
Choosing a control group in effectiveness trials of behavioral drug abuse treatments.
PMID 19553062·J Subst Abuse Treat·2009
8-other
Incentives for retention of pregnant substance users: a secondary analysis.
PMID 19577405·J Subst Abuse Treat·2010
2-rct
Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders.
PMID 19634955·J Consult Clin Psychol·2009
4-observational
Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.
PMID 18805656·Drug Alcohol Depend·2009
4-observational
Brief strategic family therapy for adolescent drug abusers: a multi-site effectiveness study.
PMID 19470315·Contemp Clin Trials·2009
4-observational
Adverse events in an integrated trauma-focused intervention for women in community substance abuse treatment.
PMID 18294804·J Subst Abuse Treat·2008
4-observational
Using buprenorphine short-term taper to facilitate early treatment engagement.
PMID 17481458·J Subst Abuse Treat·2007
4-observational
Addressing smoking in community drug abuse treatment programs: practical and policy considerations.
PMID 18303700·J Psychoactive Drugs·2007
8-other
Disseminating evidence-based practices in substance abuse treatment: a review with suggestions.
PMID 16814008·J Subst Abuse Treat·2006
6-review
A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network.
PMID 16042639·Addiction·2005
4-observational
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.
PMID 15204675·Am J Addict·2004
8-other
12-step participation as a pathway to recovery: the Maryhaven experience and implications for treatment and research.
PMID 18552722·Sci Pract Perspect·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 1009 FOY CT
CROWN POINT, IN 46307 - Phone
- (219) 662-2962
Quick Facts
- NPI
- 1972500999
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 36
- Publications
- 12
Are you this provider?
Claim Your Profile